Adenovirus type 4 a
Ended Awarded Last action
- Contract number
- SPE2DP26F5467
- Awardee
-
Teva Pharmaceuticals Usa, Inc. UEI NEN9A34LRHJ5
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $343,526
Award facts
- Contract value 100% obligated
- $343,526.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Parsippany, NJ 07054, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Defense Medical Supply Chain issued a delivery order to Teva Pharmaceuticals Usa, Inc. on May 11, 2026, with a ceiling value of $343,526.40 for Adenovirus Type 4 vaccine, with an ultimate completion date of May 19, 2026.
This is a firm fixed-price delivery order issued under the Defense Logistics Agency Troop Support Medical's Indefinite Delivery Contract (SPE2DP20D0002), which serves as the primary vehicle for Adenovirus Type 4 vaccine supply to military immunization programs. Place of performance is Parsippany, NJ. The order carries no set-aside designation.
Quick answers
Who was awarded contract SPE2DP26F5467?
SPE2DP26F5467 was awarded to Teva Pharmaceuticals Usa, Inc. by Medical Supply Chain (Troop Support) on May 11, 2026.
How much is contract SPE2DP26F5467 worth?
The government has obligated $343,526 on SPE2DP26F5467.
Is contract SPE2DP26F5467 an order under another contract?
Yes. SPE2DP26F5467 is a delivery order under SPE2DP20D0002, an indefinite delivery contract.
Was contract SPE2DP26F5467 competed?
The extent of competition for SPE2DP26F5467 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award